BAZ1A

BAZ1A (ACF1) is the non-catalytic regulatory subunit of the ISWI-family chromatin remodeling complexes ACF and CHRAC, where it partners with the SNF2H/SMARCA5 ATPase to catalyze ATP-dependent nucleosome assembly, spacing, and sliding — functions essential for heterochromatin replication, DNA damage repair, transcriptional regulation, and cell cycle checkpoint control. BAZ1A dramatically enhances SNF2H remodeling activity through its WAC motif (which binds linker DNA), DDT domain (which binds ISWI), and tandem PHD fingers (which contact core histones), collectively altering the directionality and efficiency of nucleosome mobilization (PMID:10385622, PMID:11447119, PMID:12192034, PMID:15457208, PMID:16877760). BAZ1A is recruited to DNA double-strand breaks — where it interacts with KU70 to promote both NHEJ and HR — and to UV damage sites via a DDB2–HBO1–MLL1–H3K4me1 signaling axis for global-genome nucleotide excision repair, with its bromodomain and PHD domain both required for proper loading at lesions and subsequent damage recovery (PMID:21172662, PMID:21745822, PMID:29021563, PMID:35940372). Beyond DNA repair, BAZ1A functions as a transcriptional co-repressor at nuclear receptor and Wnt target gene promoters by maintaining repressive chromatin structure, and it also participates in enhancer-driven gene activation programs through interactions with SOX2 and BRD4 (PMID:17519354, PMID:18786525, PMID:40204721).

1. 1999 High

   Establishing that ACF is a two-subunit complex (Acf1 + ISWI) answered how chromatin assembly activity greatly exceeds what the ISWI ATPase alone can achieve, defining Acf1 as an essential regulatory partner rather than a dispensable accessory.

   Evidence Purification and reconstitution of recombinant Drosophila ACF with quantitative in vitro chromatin assembly assay

   PMID:10385622

   Open questions at the time

   • Mechanism by which Acf1 enhances ISWI activity was unknown
   • Whether this complex exists in mammalian cells was untested
2. 2001 High

   Identification of Acf1 as the p175 subunit of CHRAC and demonstration that it enhances nucleosome sliding by an order of magnitude and alters sliding directionality resolved whether CHRAC and ACF share a common regulatory subunit and established that Acf1 qualitatively reprograms the ISWI motor.

   Evidence Biochemical purification of CHRAC, mass spectrometry, in vitro nucleosome remodeling assay with and without Acf1

   PMID:11447119

   Open questions at the time

   • Which domains of Acf1 confer these effects was unknown
   • Histone tail requirements for Acf1-modified sliding unresolved
3. 2002 High

   Systematic domain dissection of Acf1 mapped WAC motif to DNA binding, DDT domain to ISWI interaction, and PHD/bromodomain to chromatin engagement, answering how a single regulatory subunit coordinates multiple substrate contacts to enhance remodeling.

   Evidence Deletion/point mutagenesis of Drosophila Acf1 with DNA-binding, ATPase, and chromatin assembly assays

   PMID:12192034

   Open questions at the time

   • Structural basis of each domain–substrate interaction unresolved
   • Relative contributions of each domain in vivo unknown
4. 2002 High

   Demonstrating that ACF1–SNF2H is specifically required for replication through pericentromeric heterochromatin in mammalian cells established the first in vivo cellular function for the human complex, linking it to condensed chromatin duplication and S-phase progression.

   Evidence RNAi knockdown, BrdU incorporation/replication timing, immunofluorescence, dominant-negative mutant in mammalian cells

   PMID:12434153

   Open questions at the time

   • Whether ACF1 remodels nucleosomes ahead of or behind the replication fork was unclear
   • Relationship to heterochromatin maintenance marks unresolved
5. 2004 High

   Two complementary studies — one showing PHD fingers tether ACF to histones for efficient nucleosome mobilization in vitro, the other demonstrating in vivo that Acf1 loss disrupts nucleosome periodicity, heterochromatin silencing, and Polycomb repression — together established that ACF1's histone-contact domains are essential for building repressive chromatin architecture.

   Evidence PHD mutagenesis/zinc chelation with reconstituted complex (in vitro); Acf1-null Drosophila with MNase laddering, position-effect variegation, and genetic epistasis (in vivo)

   PMID:14752009 PMID:15457208

   Open questions at the time

   • Whether PHD fingers recognize specific histone modifications was untested
   • Mechanism of Polycomb cooperation was indirect
6. 2006 High

   Reconstituted human ACF showed that hACF1 alters the DNA overhang requirement and accessibility profile of remodeled products, answering how the accessory subunit changes the physical mechanism of nucleosome translocation by SNF2H.

   Evidence Reconstituted hACF complex with varied DNA overhang lengths and restriction enzyme accessibility assay

   PMID:16877760

   Open questions at the time

   • Single-molecule resolution of translocation mechanism lacking
   • Whether overhang sensing reflects a physiological ruler mechanism unclear
7. 2007 Medium

   Discovery that BAZ1A acts as a transcriptional co-repressor at VDR target genes — stabilizing N-CoR at promoters and modifying histone marks — expanded the functional repertoire of ACF1 beyond replication and chromatin assembly to signal-dependent transcriptional regulation.

   Evidence Yeast two-hybrid, co-immunoprecipitation with N-CoR, ChIP at VDR target promoters, RNAi knockdown

   PMID:17519354

   Open questions at the time

   • Whether ACF1 co-repressor function requires SNF2H ATPase activity was not tested
   • Genome-wide scope of co-repressor activity unknown
8. 2008 Medium

   Showing that Drosophila ACF1/ISWI directly repress Wingless/Wnt target genes by maintaining a repressive chromatin barrier that antagonizes H4 acetylation extended the transcriptional repressor role to a conserved developmental signaling pathway.

   Evidence ChIP, RNAi of ISWI/ACF1, reporter assays, histone modification analysis in Drosophila

   PMID:18786525

   Open questions at the time

   • Identity of acetyltransferase opposed by ACF1 was not determined
   • Whether mammalian Wnt signaling uses the same mechanism untested
9. 2010 High

   BAZ1A was shown to rapidly accumulate at DNA double-strand breaks, interact directly with KU70, and be required for both NHEJ and HR, establishing ACF/CHRAC as a bona fide DNA damage response complex and not merely a replication factor.

   Evidence Laser microirradiation with live-cell imaging, co-immunoprecipitation with KU70, NHEJ/HR reporter assays, clonogenic survival after RNAi

   PMID:21172662

   Open questions at the time

   • Chromatin remodeling mechanism at DSBs not directly measured
   • Whether ACF1 recruitment is upstream or downstream of KU loading was ambiguous
10. 2011 High

    Demonstration that BAZ1A depletion compromises the G2/M DNA damage checkpoint — reducing γH2AX and CHK2 phosphorylation and causing cells to enter mitosis with unrepaired damage — linked the chromatin remodeler to checkpoint signaling, not just repair per se.

    Evidence RNAi, laser microirradiation, flow cytometry, γH2AX/CHK2ph immunofluorescence, clonogenic survival

    PMID:21745822

    Open questions at the time

    • Whether BAZ1A directly promotes ATM/ATR signaling or acts indirectly via chromatin accessibility unclear
    • Relationship between replication and checkpoint functions not disentangled
11. 2017 High

    Structural and mutational analysis revealed that the BAZ1A PHD domain non-canonically binds DNA rather than methylated histones, and that both the PHD and a weak-binding bromodomain are required for loading at damage sites and DNA damage recovery — resolving the reader-module logic of BAZ1A recruitment.

    Evidence X-ray crystallography/structural analysis, biochemical binding assays, CRISPR domain mutants, laser microirradiation imaging, clonogenic survival

    PMID:29021563

    Open questions at the time

    • Which histone mark, if any, the bromodomain reads in vivo remained uncertain
    • Whether PHD-DNA binding contributes to replication or transcription functions untested
12. 2022 Medium

    Placing BAZ1A recruitment at UV damage sites downstream of a DDB2→HBO1→MLL1→H3K4me1 signaling axis resolved how the NER-specific damage sensor communicates with the chromatin remodeler to facilitate CPD removal in GG-NER.

    Evidence siRNA epistasis experiments, ChIP, immunofluorescence at UV-irradiated sites, CPD removal assay

    PMID:35940372

    Open questions at the time

    • Whether BAZ1A reads H3K4me1 directly or is recruited through an intermediary was not determined
    • Contribution of BAZ1A bromodomain versus PHD to UV-site recruitment not dissected
13. 2024 Medium

    Evidence that ACF1 and SMARCA5 accumulate at DNA breaks independently of each other — not via direct ADP-ribose binding but through facilitated access to relaxed, PARylated chromatin — revised the model of how the complex reaches damage sites.

    Evidence Live-cell laser microirradiation, PARP inhibitor treatment, ADP-ribose binding assays, FRAP

    PMID:38170578

    Open questions at the time

    • What DNA or chromatin feature ACF1 binds at relaxed chromatin was not identified
    • Whether independent recruitment leads to de novo complex assembly at breaks is unknown
14. 2024 Low

    A short alternatively spliced BAZ1A isoform generated by the DBIRD splicing complex was shown to lack linker DNA access and fail to restore DNA repair, indicating that full-length-specific regions are functionally essential.

    Evidence Knockout rescue with full-length vs. short isoform, DNA damage marker assays, phleomycin sensitivity

    PMID:39112459

    Open questions at the time

    • Precise exons and domains missing in the short isoform not fully characterized
    • Physiological contexts where the short isoform is expressed remain unclear
    • Single study without independent replication
15. 2025 Medium

    Discovery that USP10 stabilizes BAZ1A via deubiquitination and that BAZ1A partners with SOX2 to drive enhancer–promoter interactions and BRD4 recruitment revealed a chromatin-activating role in cancer stem cell transcription programs, distinct from its canonical repressive functions.

    Evidence Co-immunoprecipitation, ubiquitination assay, ChIP, enhancer-promoter conformation assay, shRNA knockdown in HNSCC cells

    PMID:40204721

    Open questions at the time

    • Whether SOX2–BAZ1A interaction requires SMARCA5 untested
    • Genome-wide enhancer targets of BAZ1A–SOX2 not mapped
    • Whether BAZ1A activating role generalizes beyond HNSCC unknown

• Key unresolved questions include: the structural basis for how BAZ1A reprograms ISWI motor directionality, how BAZ1A's repressive (nucleosome spacing/co-repressor) and activating (enhancer/SOX2/E2F1) functions are partitioned across genomic contexts, and whether BAZ1A reader domains (PHD-DNA, bromodomain-acetyl-histone) serve as context-specific targeting switches.
• No high-resolution cryo-EM structure of full-length ACF complex exists
• Genome-wide mapping of BAZ1A occupancy at baseline and after damage in a single system is lacking
• Regulatory logic governing switch between repressive and activating functions is undetermined